Recent Guidelines on Adenotonsillectomy
The 2019 American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) Clinical Practice Guideline for tonsillectomy in children provides the most comprehensive and recent evidence-based recommendations for adenotonsillectomy management, with specific criteria for surgical indications, perioperative care, and postoperative monitoring to reduce morbidity and mortality.
Indications for Adenotonsillectomy
Recurrent Throat Infections
- Tonsillectomy may be recommended for recurrent throat infections with:
- At least 7 episodes in the past year, OR
- At least 5 episodes per year for 2 years, OR
- At least 3 episodes per year for 3 years 1
- Each episode must be documented with:
- Temperature ≥38.3°C (101°F)
- Cervical adenopathy
- Tonsillar exudate
- Positive test for group A beta-hemolytic streptococcus 1
Obstructive Sleep-Disordered Breathing (oSDB)
- Strong recommendation for tonsillectomy in children with obstructive sleep apnea documented by polysomnography 1
- Clinicians should assess for comorbid conditions that may improve after tonsillectomy:
- Growth retardation
- Poor school performance
- Enuresis
- Asthma
- Behavioral problems 1
Preoperative Evaluation
Polysomnography Recommendations
Mandatory polysomnography referral before tonsillectomy for children with oSDB who:
- Are <2 years of age
- Have obesity
- Have Down syndrome
- Have craniofacial abnormalities
- Have neuromuscular disorders
- Have sickle cell disease
- Have mucopolysaccharidoses 1
Polysomnography should be advocated for children with oSDB when:
- Need for tonsillectomy is uncertain
- Discordance exists between physical examination and reported severity 1
Special Populations
- Children with sickle cell disease:
- Require pre-operative transfusion as per standard guidance
- Need special attention for those with high transcranial Doppler flows (stroke risk)
- May need nasopharyngeal airway placement during surgery 1
Perioperative Management
Medication Recommendations
- Strong recommendation for a single intraoperative dose of intravenous dexamethasone (0.5 mg/kg) to reduce pain and postoperative nausea 1, 2
- Strong recommendation against routine perioperative antibiotics 1
- Strong recommendation against codeine or any medication containing codeine after tonsillectomy in children younger than 12 years 1
- Postoperative pain management should include:
Postoperative Care
Monitoring Requirements
- Arrange for overnight inpatient monitoring for children who are:
- <3 years old
- Have severe OSA (AHI ≥10 obstructive events/hour)
- Have oxygen saturation nadir <80% 1
Bleeding Assessment
- Clinicians should:
- Follow up with patients/caregivers after tonsillectomy
- Document presence/absence of bleeding within 24 hours (primary bleeding)
- Document bleeding occurring later than 24 hours (secondary bleeding)
- Determine their rate of primary and secondary post-tonsillectomy bleeding at least annually 1
Patient Education
- Counsel patients and caregivers that:
- oSDB may persist or recur after tonsillectomy and may require further management
- Postoperative pain management is crucial and requires anticipation, reassessment, and adequate treatment 1
Potential Complications
Common Complications
- Postoperative hemorrhage (primary and secondary)
- Pain, otalgia, fever, dehydration
- Velopharyngeal incompetence
- Airway risks and aspiration 3, 4
Rare Complications
- Atlantoaxial subluxation (Grisel syndrome)
- Nasopharyngeal stenosis
- Taste disorders
- Persistent neck pain (Eagle syndrome) 3, 4
Special Considerations
High-Risk Patients
- Children with hematologic disorders require:
- Proper preoperative screening
- Specialized perioperative management 5
- Children with Prader-Willi syndrome:
- Higher risk of postoperative residual OSA
- Higher complication rates 6
Quality Improvement Opportunities
- Implement shared decision-making with patients/caregivers
- Document outcomes assessment for bleeding
- Avoid routine use of antibiotics and codeine
- Ensure appropriate pain management strategies 1
The 2019 AAO-HNS guideline represents a significant update from the 2011 version, with seven new key action statements and modifications to five existing statements, reflecting the evolution of evidence-based practice in adenotonsillectomy management 1.